Immunotherapy in Multiple Myeloma : Emerging Strategies

Immunotherapy in Multiple Myeloma : Emerging Strategies is organized by prIME oncology Oncology and will be held during Mar 31, 2017 - Mar 31, 2018.

The target audience for this medical event is specifically designed to meet the needs of medical oncologists, hematologists, and other healthcare professionals involved in the treatment of patients with multiple myeloma. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.

Conference Objectives are :

After completion of this educational activity, participants should be able to:
• Describe current novel immunotherapy options in relapsed/refractory (R/R) multiple myeloma
• Tailor/individualize immunotherapy in multiple myeloma to disease burden and biology
• Explain the biology behind immunotherapy in R/R multiple myeloma and the future of immunotherapeutic approaches

Additional details will be posted as soon as they are available.